Cargando…
Oral anticoagulation following bioprosthetic SAVR in patients with atrial fibrillation: what’s the current status of NOACs?
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252115/ https://www.ncbi.nlm.nih.gov/pubmed/35522014 http://dx.doi.org/10.1093/icvts/ivac112 |
_version_ | 1784740192055197696 |
---|---|
author | Milojevic, Milan Nikolic, Aleksandar Micovic, Slobodan Jeppsson, Anders |
author_facet | Milojevic, Milan Nikolic, Aleksandar Micovic, Slobodan Jeppsson, Anders |
author_sort | Milojevic, Milan |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9252115 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-92521152022-07-05 Oral anticoagulation following bioprosthetic SAVR in patients with atrial fibrillation: what’s the current status of NOACs? Milojevic, Milan Nikolic, Aleksandar Micovic, Slobodan Jeppsson, Anders Interact Cardiovasc Thorac Surg Adult Cardiac Oxford University Press 2022-05-06 /pmc/articles/PMC9252115/ /pubmed/35522014 http://dx.doi.org/10.1093/icvts/ivac112 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Adult Cardiac Milojevic, Milan Nikolic, Aleksandar Micovic, Slobodan Jeppsson, Anders Oral anticoagulation following bioprosthetic SAVR in patients with atrial fibrillation: what’s the current status of NOACs? |
title | Oral anticoagulation following bioprosthetic SAVR in patients with atrial fibrillation: what’s the current status of NOACs? |
title_full | Oral anticoagulation following bioprosthetic SAVR in patients with atrial fibrillation: what’s the current status of NOACs? |
title_fullStr | Oral anticoagulation following bioprosthetic SAVR in patients with atrial fibrillation: what’s the current status of NOACs? |
title_full_unstemmed | Oral anticoagulation following bioprosthetic SAVR in patients with atrial fibrillation: what’s the current status of NOACs? |
title_short | Oral anticoagulation following bioprosthetic SAVR in patients with atrial fibrillation: what’s the current status of NOACs? |
title_sort | oral anticoagulation following bioprosthetic savr in patients with atrial fibrillation: what’s the current status of noacs? |
topic | Adult Cardiac |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252115/ https://www.ncbi.nlm.nih.gov/pubmed/35522014 http://dx.doi.org/10.1093/icvts/ivac112 |
work_keys_str_mv | AT milojevicmilan oralanticoagulationfollowingbioprostheticsavrinpatientswithatrialfibrillationwhatsthecurrentstatusofnoacs AT nikolicaleksandar oralanticoagulationfollowingbioprostheticsavrinpatientswithatrialfibrillationwhatsthecurrentstatusofnoacs AT micovicslobodan oralanticoagulationfollowingbioprostheticsavrinpatientswithatrialfibrillationwhatsthecurrentstatusofnoacs AT jeppssonanders oralanticoagulationfollowingbioprostheticsavrinpatientswithatrialfibrillationwhatsthecurrentstatusofnoacs |